Mindmed announces partnership with datavant, a leading health data connectivity company

New york, july 8, 2021 /prnewswire/ -- mindmed (nasdaq: mnmd, neo: mmed, de: mmq), a leading biotech company developing psychedelic-inspired therapies, and datavant, inc. ("datavant"), a leader in helping healthcare organizations safely connect their data, announced a partnership through which mindmed will use datavant's privacy-protecting technology to link mindmed's clinical trial data to external data from both clinical and real-world sources.  mindmed plans to use datavant's linking technology across various stages of the drug lifecycle including discovery, clinical development, and commercialization.
MNMD Ratings Summary
MNMD Quant Ranking